| Literature DB >> 35889874 |
Philipp Ockermann1, Rosario Lizio2, Jan Hansmann1.
Abstract
Oxidative stress and inflammation play a pivotal role in the development of cardiovascular diseases, an ever-growing worldwide problem. As a non-pharmacological approach, diet, especially a flavonoid-rich diet, showed promising results in the reduction of cardiovascular diseases and alleviation of their symptoms. In this study, in vitro systems based on human microvascular endothelial cells (hmvEC) and human umbilical cord endothelial cells (HUVEC) were established to determine the effect of Healthberry 865® (HB) and ten of its relating single anthocyanins on oxidative stress. Furthermore, five metabolites were used in order to examine the effect of anthocyanin's most common breakdown molecules. The results showed an effect of HB in both models after 24 h, as well as most of its single anthocyanins. Cyanidin-rutinoside, peonidin-galactoside, and petunidin-glucoside had a model-specific effect. For the metabolites, phloroglucinaldeyhde (PGA) showed an effect in both models, while vanillic acid (VA) only had an effect in HUVEC. When combined, a combination of several anthocyanins did not have a cumulative effect, except for combining glucosides in hmvEC. The combination of PGA and VA even revealed an inhibitive behavior. Overall, the study demonstrates the antioxidative effect of HB and several of its single anthocyanins and metabolites, which are partially model specific, and coincides with animal studies.Entities:
Keywords: HUVEC; anthocyanins; microvascular endothelial cells; reactive oxygen species
Mesh:
Substances:
Year: 2022 PMID: 35889874 PMCID: PMC9325219 DOI: 10.3390/nu14142917
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Figure 1DCF-DA fluorescence relative to control with the respective concentrations of HB in HUVEC (A) and hmvEC (B); results are expressed as mean ± SD; * p < 0.05 compared to 0 µg/mL HB; n = 4 technical replicates.
Figure 2DCF-DA fluorescence relative to control in hmvEC with the respective concentrations of single anthocyanins (A,B) and the respective concentrations of anthocyanin metabolites (C); results are expressed as mean ± SD; * p < 0.05 compared to 0 µg/mL of the respective substance; n = 4 technical replicates.
Figure 3DCF-DA fluorescence relative to control in HUVEC with the respective concentrations of single anthocyanins (A,B) and the respective concentrations of anthocyanin metabolites (C); results are expressed as mean ± SD; * p < 0.05 compared to 0 µg/mL of the respective substance; n = 4 technical replicates.
Anthocyanin mixtures used; concentrations were equimolar cumulative.
| Name | Anthocyanins |
|---|---|
| Mix 1 | C3gal + C3glu + C3 rut |
| Mix 2 | D3ara + D3gal + D3glu + D3rut |
| Mix 3 | C3glu + D3glu + M3glu |
| Mix 4 | C3rut + D3rut |
| Mix 5 | C3gal + C3glu + C3rut + D3ara + D3gal + D3glu + D3rut + M3glu |
| Mix 6 | vanillic acid + phloroglucinaldehyde |
Figure 4DCF-DA fluorescence relative to control in HUVEC (A) and hmvEC (B) with the respective cumulative concentration and respective anthocyanin or metabolite (C) combinations; results are expressed as mean ± SD; * p < 0.05 compared to 0 µg/mL of the respective mix; n = 4 technical replicates.